Inside informationEnglish
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 28/03/2026, 16:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 112787_20260328